ArticleBriefings in bioinformatics2026
Shoebill: an interpretable AlphaFold2-informed predictor of protein crystallization propensity using XGBoost.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
X-ray crystallography is a central technique for high-resolution protein structure determination; however, the production of diffraction-quality crystals remains a major bottleneck due to high experimental cost and low success rates. Computational prediction of protein crystallization propensity offers a promising strategy to prioritize targets and reduce unnecessary experimental screening. While numerous computational predictors have been proposed, many rely primarily on sequence-derived features or provide limited interpretability, thereby offering little practical guidance for experimental design. Here, we present Shoebill, an interpretable protein crystallization propensity predictor that integrates AlphaFold2 (AF2)-derived structural descriptors with an XGBoost framework to assess whether a protein-assuming successful expression and purification-is likely to form diffraction-quality crystals. Shoebill leverages a comprehensive feature set extracted directly from AF2-predicted structures, capturing complementary structural information beyond sequence alone, including structural disorder, AF2 confidence metrics, molecular geometry, and surface physicochemical properties. On our primary independent benchmark, Shoebill outperforms existing nondeep-learning crystallization propensity predictors while maintaining balanced sensitivity and specificity, improving the area under the receiver operating characteristic curve from 0.700 to 0.804 and more than doubling the Matthews correlation coefficient from 0.123 to 0.297 relative to DCFCrystal, the best-performing nondeep-learning method. Although the deep learning-based predictor SADeepcry achieves higher overall predictive accuracy, Shoebill provides feature-level explanations for individual predictions through SHAP analysis, highlighting biologically meaningful features associated with crystallization propensity that may help guide rational strategies for construct optimization. The Shoebill source code and a user-friendly web server are publicly available at https://github.com/KJ-Liao/Shoebill.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.